9 Meters Biopharma, Inc.

NMTRQOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$145

P/E Ratio—

52W High$0.0005

52W Low$0.00001

Avg Volume13

Open$0.00

Beta9.33

Earnings Financials Revenue

9 Meters Biopharma, Inc. (NMTRQ) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

NMTRQ · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Rev. $6.21B

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

Rev. Est.$6.21B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 17, 2026	—	—	—	—	—	—
◌ Q2 FY2026	May 29, 2026	—	—	—	—	—	—
◌ Q1 FY2026	Mar 31, 2026	-$1.16	—	—	—	—	—
◌ Q3 FY2024	Aug 9, 2024	—	—	—	—	—	—
◌ Q2 FY2024	Jun 28, 2024	—	—	—	—	—	—
◌ Q1 FY2024	Feb 12, 2024	—	—	—	—	—	—
◌ Q4 FY2023	Nov 14, 2023	-$0.44	—	—	—	—	—
◌ Q3 FY2023	Jul 1, 2023	-$0.44	—	—	—	—	—

Q3 FY2026

Aug 17, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 29, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 31, 2026

EPS Actual

—

EPS Est.

-$1.16

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 9, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

Jun 28, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Feb 12, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2023

Nov 14, 2023

EPS Actual

—

EPS Est.

-$0.44

EPS Surpr.

—

Revenue

—

Q3 FY2023

Jul 1, 2023

EPS Actual

—

EPS Est.

-$0.44

EPS Surpr.

—

Revenue

—

No analyst estimates available for NMTRQ.

About Earnings & Data Methodology

9 Meters Biopharma, Inc. (NMTRQ) reports earnings quarterly as a OTC-listed Biotechnology company. The next NMTRQ earnings date is expected around September 1, 2026.

Each quarter, investors track NMTRQ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NMTRQ revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

NMTRQ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

NMTRQ earnings · 3 questions

9 Meters Biopharma, Inc.'s next earnings report is expected around September 1, 2026. NMTRQ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NMTRQ historically reports after market close (AMC).

NMTRQ earnings datewhen is NMTRQ earningsNMTRQ next earnings datewhen does NMTRQ report earningsNMTRQ earnings calendar

▸ Source: FMP · 9 Meters Biopharma, Inc. SEC filings · US GAAP · 9 Meters Biopharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026